These Healthcare stocks are trading higher:
-IN8BIO, Inc. (INAB) stock is trading at $3.95, an increase of $0.75, or 23.44%, on high volume. In8Bio Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.50. In8Bio Inc next reports earnings on February 9.
-Haemonetics Corporation (HAE) stock is trading at $55.05, an increase of $8.08, or 17.2%, on high volume. Haemonetics Corp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $74.86.
-BioCardia Inc (BCDA) stock is trading at $2.44, a rise of $0.35, or 17.14%, on high volume. Biocardia Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.33.
-Oncology Pharma Inc (ONPH) stock is trading at $5.16, a gain of $0.72, or 16.22%, on high volume. Oncology Pharma Inc gets a Sentiment Score of Very Bullish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Pulse Biosciences Inc (PLSE) stock is trading at $7.24, a drop of $3.62, or 33.07%, on high volume. Pulse Biosciences CS gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $35.33. Pulse Biosciences CS next reports earnings on February 28.-Karyopharm Therapeutics Inc (KPTI) stock is trading at $8.03, a loss of $2.22, or 22.02%, on high volume. Karyopharm Therapeut gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00.
-Novavax, Inc. (NVAX) stock is trading at $80.99, a loss of $13.81, or 14.03%, on average volume. Novavax Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $250.00. Novavax Inc next reports earnings on March 7.
-Mirati Therapeutics Inc (MRTX) stock is trading at $107.58, a decline of $13.12, or 10.69%, on high volume. Mirati Therapeutics gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $188.88. Mirati Therapeutics next reports earnings on February 24.
